Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4–5 chronic kidney disease: a systematic review and meta-analysis

DOI: 10.1186/s12985-019-1140-x

Keywords: HCV infection, Stage 4–5 chronic kidney disease, Sofosbuvir, Dose, Meta-analysis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text